Company news
Phathom Pharmaceuticals, Inc. news in 2020
Phathom Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.
Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock
December 14, 2020
Phathom Pharmaceuticals Announces Plans to Initiate Vonoprazan Development Program in Non-Erosive Reflux Disease (NERD)
December 13, 2020
Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Erosive Esophagitis Trial
November 29, 2020
Phathom Pharmaceuticals to Participate at Upcoming Investor Healthcare Conferences
November 26, 2020
Phathom Pharmaceuticals to Host Virtual Investor Day
November 18, 2020
Phathom Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
November 12, 2020
Phathom Pharmaceuticals Reports Third Quarter 2020 Results and Provides Update on Phase 3 Trials
November 9, 2020
Phathom Pharmaceuticals to Present at Morgan Stanley 18th Annual Global Healthcare Conference
September 8, 2020
Phathom Pharmaceuticals Reports Second Quarter 2020 Results
August 5, 2020
Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer
July 12, 2020
Phathom Pharmaceuticals Provides Clinical Trial Status Update
June 14, 2020
Phathom Pharmaceuticals to Present at Upcoming Investor Conferences
May 27, 2020
Phathom Pharmaceuticals Reports First Quarter 2020 Results
May 11, 2020
Phathom to Participate at the 19th Annual Needham Virtual Healthcare Conference
April 8, 2020
Phathom Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Clinical Trial Status and Business Updates
March 18, 2020
Phathom Pharmaceuticals to Present at 40th Annual Cowen and Company Health Care Conference on March 2, 2020
February 24, 2020
Phathom Pharmaceuticals Appoints Martin J. Gilligan as Chief Commercial Officer
January 5, 2020